Company profile
Strata Critical Medical, Inc.
NASDAQ: SRTA · Healthcare · Medical - Care Facilities
#290 of 1,420 Healthcare companies by revenue28th-percentile growth
EA Score
60CFH 77DQ 46GM 36SS 62
v0.1 · 65/100 weight · provisional
↑ return on assets, net margin · ↓ Piotroski F, growth stability
Methodology →Revenue TTM
$254.3M
Rev growth YoY (TTM)
+1.1%
Net income (FY)
$41.3M
Employees
327
as of 2026-08-12
Market cap
$521.8M
as of 2026-08-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$197.1M$197.1M2025
Net income$41.3M$41.3M2025
Operating income-$22.4M-$22.4M2025
Total assets$325.5M$325.5M2025
Liabilities$46.4M$46.4M2025
Equity$279.1M$279.1M2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY21
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Logistics90%
Clinical10%
By geography
Not disclosed.
The read
What is Strata Critical Medical, Inc.’s revenue?
Strata Critical Medical, Inc. booked $197.1M in FY2025 revenue, contracting 21% year over year — slower than 72% of Healthcare companies we track, at a 21.0% net margin.
Peers · Healthcare
Canopy Growth Corporation59CCytek Biosciences, Inc.58CSI-BONE, Inc.70BLifeMD, Inc.73Bbiote Corp.63CRhythm Pharmaceuticals, Inc.60CNeighbors
New York →Key facts
CEOMelissa Tomkiel
SectorHealthcare
IndustryMedical - Care Facilities
HeadquartersNew York, NY
ExchangeNASDAQ: SRTA
Employees327
IPO date2019-11-05
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.